[go: up one dir, main page]

DE60313858D1 - Peptidhaltige kosmetische oder pharmazeutische zusammensetzung - Google Patents

Peptidhaltige kosmetische oder pharmazeutische zusammensetzung

Info

Publication number
DE60313858D1
DE60313858D1 DE60313858T DE60313858T DE60313858D1 DE 60313858 D1 DE60313858 D1 DE 60313858D1 DE 60313858 T DE60313858 T DE 60313858T DE 60313858 T DE60313858 T DE 60313858T DE 60313858 D1 DE60313858 D1 DE 60313858D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
peptide containing
containing cosmetic
cosmetic
pentadecapeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60313858T
Other languages
English (en)
Inventor
Farra Claude Dal
Nouha Domloge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Societe dExtraction des Principes Actifs SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExtraction des Principes Actifs SA filed Critical Societe dExtraction des Principes Actifs SA
Application granted granted Critical
Publication of DE60313858D1 publication Critical patent/DE60313858D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60313858T 2002-03-18 2003-03-14 Peptidhaltige kosmetische oder pharmazeutische zusammensetzung Expired - Lifetime DE60313858D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0203306A FR2837098B1 (fr) 2002-03-18 2002-03-18 Composition cosmetique ou pharmaceutique comprenant des peptides, procedes de traitement et utilisations
PCT/FR2003/000817 WO2003077936A1 (fr) 2002-03-18 2003-03-14 Composition cosmetique ou pharmaceutique comprenant des peptides

Publications (1)

Publication Number Publication Date
DE60313858D1 true DE60313858D1 (de) 2007-06-28

Family

ID=27772200

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60313858T Expired - Lifetime DE60313858D1 (de) 2002-03-18 2003-03-14 Peptidhaltige kosmetische oder pharmazeutische zusammensetzung

Country Status (7)

Country Link
US (1) US7396815B2 (de)
EP (1) EP1490092B1 (de)
AT (1) ATE362373T1 (de)
AU (1) AU2003242817A1 (de)
DE (1) DE60313858D1 (de)
FR (1) FR2837098B1 (de)
WO (1) WO2003077936A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2927079B1 (fr) * 2008-02-06 2012-09-21 Soc Extraction Principes Actif Nouveau peptide et composition cosmetique et/ou pharmaceutique le contenant
US7701550B2 (en) 2004-08-19 2010-04-20 Asml Netherlands B.V. Lithographic apparatus and device manufacturing method
FR2893502A1 (fr) 2005-11-21 2007-05-25 Oreal Procede cosmetique de soin de la peau utilisant des contraintes mecaniques
FR2893501B1 (fr) * 2005-11-21 2014-03-14 Oreal Compositions topiques pour favoriser l'homeostasie de la peau
TWI415628B (zh) 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
FR2903305B1 (fr) * 2006-07-07 2012-06-01 Soc Extraction Principes Actif Utilisation d'extraits vegetaux en tant que principes actifs amincissants
FR2915395B1 (fr) * 2007-04-27 2012-03-09 Vincience Composition pharmaceutique et/ou cosmetique contenant des peptides
FR2915391B1 (fr) 2007-04-27 2011-08-12 Soc Extraction Principes Actif Composition pharmaceutique et/ou cosmetique contenant un principe actif antioxydant et activateur de l'energie cellulaire.
FR3034664B1 (fr) 2015-04-09 2018-09-14 ISP Investments LLC. Extrait hydro-alcoolique de schinus molle, compositions cosmetiques le comprenant et leurs utilisations cosmetiques
FR3043695B1 (fr) 2015-11-17 2019-10-25 ISP Investments LLC. Procede d'obtention d'un extrait aqueux enrichi en petits arn a partir d'une matiere vegetal et extraits issus du procede
FR3048610B1 (fr) 2016-03-08 2020-03-27 ISP Investments LLC. Corps gras active et/ou cire activee au moyen de la fraction non hydrosoluble du suc de carica papaya
JP6861820B2 (ja) 2016-09-07 2021-04-21 アイエスピー インベストメンツ エルエルシー モモ（ｐｒｕｎｕｓ ｐｅｒｓｉｃａ）の水性抽出物およびその調製方法
FR3062568B1 (fr) 2017-02-09 2020-10-23 Isp Investments Llc Extraits de la liane marsdenia cundurango, compositions cosmetiques les comprenant et leurs utilisations cosmetiques.
CN108721155B (zh) 2017-04-14 2023-03-17 Isp投资有限公司 含有白松露提取物的化妆品制备物和其化妆方法
FR3066113B1 (fr) 2017-05-12 2020-06-05 ISP Investments LLC. Procede d’obtention d’un extrait aqueux d’anethum graveolens enrichi en petits arn
FR3077204B1 (fr) 2018-01-30 2021-09-17 Isp Investments Llc Extraits de fruit de myrciaria dubia riche en acides organiques, compositions cosmetiques le comprenant et leurs utilisations cosmetiques
FR3091993B1 (fr) 2019-01-29 2021-01-22 Isp Investments Llc Procede d’obtention d’un extrait de feuilles de patchouli et ses utilisations cosmetiques
FR3106754B1 (fr) 2020-02-04 2022-01-07 Isp Investments Llc Procede d’obtention d’un extrait aqueux de lavande, compositions comprenant un tel extrait et leurs utilisations cosmetiques
FR3110425B1 (fr) 2020-05-19 2022-09-09 Isp Investments Llc Procede d’obtention d’un extrait de bois de santal, compositions le comprenant et ses utilisations cosmetiques
CN114081852A (zh) 2020-08-25 2022-02-25 Isp投资有限公司 改善皮肤外观的组合物和方法
FR3116438B1 (fr) 2020-11-23 2022-10-14 Isp Investments Llc Procede d’obtention d’extraits aqueux de feuilles de thes, compositions comprenant de tels extraits et leurs utilisations cosmetiques
FR3125425B1 (fr) 2021-07-22 2024-09-13 Isp Investments Llc Extrait de feuilles de the noir, compositions le comprenant et ses utilisations cosmetiques
FR3146596B1 (fr) 2023-03-15 2026-01-23 Isp Investments Llc Procede d’obtention d’un extrait de bois de rose, compositions le comprenant et ses utilisations cosmetiques
FR3164389A1 (fr) 2024-07-11 2026-01-16 Isp Investments Procede de preparation de complexes moleculaires non covalents comprenant de l’acide hyaluronique et au moins une fraction peptidique, compositions cosmetiques et pharmaceutiques le comprenant et leurs utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61238712A (ja) * 1985-04-17 1986-10-24 Shiseido Co Ltd 皮膚化粧料
US5696229A (en) * 1995-03-16 1997-12-09 The University Of Virginia Patent Foundation Polypeptide with laminin cell adhesion and morphogenesis activity
DE19653736C2 (de) * 1996-12-12 2002-11-21 Lancaster Group Gmbh Kosmetisches Präparat mit Peptidzusatz
US5958874A (en) * 1998-02-18 1999-09-28 The Research Foundation Of State University Of New York Recombinant fibronectin-based extracellular matrix for wound healing
US6635616B2 (en) * 2000-05-01 2003-10-21 The General Hospital Corporation Laminin 15

Also Published As

Publication number Publication date
US20050124545A1 (en) 2005-06-09
AU2003242817A1 (en) 2003-09-29
FR2837098A1 (fr) 2003-09-19
ATE362373T1 (de) 2007-06-15
US7396815B2 (en) 2008-07-08
FR2837098B1 (fr) 2004-05-28
EP1490092A1 (de) 2004-12-29
WO2003077936A1 (fr) 2003-09-25
EP1490092B1 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
DE60313858D1 (de) Peptidhaltige kosmetische oder pharmazeutische zusammensetzung
DK0883687T3 (da) C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
ITBS960094A0 (it) Composizione per uso cosmetico farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
EP1092774A3 (de) Borrelia burgdorferi Antigen OspA, dafür kodierendes Gen und ihre Verwendungen
DK1478328T3 (da) Bioaktive keratinpeptider
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
CY1110868T1 (el) Ελαχιστη αλληλουχια dna που δρα ως μονωτης της χρωματινης και η χρηση της στην πρωτεϊνικη εκφραση
WO2005030797A3 (en) Melanocortin receptor agonists
WO2002079408A3 (en) Short bioactive peptides and methods for their use
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
NO20040880L (no) Casein avledete peptider og anvendelser derav i terapi.
DK1219301T3 (da) Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner
AU2003285385A1 (en) The transmembrane protein amigo and uses thereof
ATE391489T1 (de) Haarbehandlungszusammensetzungen
JP2005535281A5 (de)
DE69737561D1 (de) Klonierte rezeptoren des glukagon-ähnlichen peptids-2
IT1286829B1 (it) Plasmidi contenenti due o piu' competitori disposti in successione e loro uso in tecniche di pcr-competitiva
WO2002066513A3 (de) Humane zirkulierende lekti fragmente hf7072, hf7638 und hf14448 sowie ihre verwendung
WO2004000870A3 (en) Two synthetic peptides for treatment and prevention of cancers
WO2002072611A8 (en) Novel human egf-family proteins and polynucleotides encoding the same
ATE332923T1 (de) Cr1 fragmente und deren verwendung
AU2003235993A1 (en) Clarin polypeptides, polynucleotides encoding same and uses thereof in diagnosis and treatment of usher's syndrome
AU2001275337A1 (en) Novel human transporter proteins and polynucleotides encoding the same
AU2003213933A1 (en) Purified polypeptides involved in protein synthesis and modification

Legal Events

Date Code Title Description
8332 No legal effect for de